Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: A case report

Netherlands Journal of Medicine

Volumn 63, Issue 8, 2005, Pages 316-318

  Hanekamp, B B ^a   Zijlstra, J G ^a   Tulleken, J E ^a   Ligtenberg, J J M ^a   van der Werf, T S ^a   Hofstra, L S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Rhabdomyolysis; Self poisoning; Serotonin syndrome; Venlafaxine

Indexed keywords

ACTIVATED CARBON; BICARBONATE; CLONAZEPAM; CREATINE KINASE; LAXATIVE; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DISORIENTATION; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; FEVER; HUMAN; HYDRATION; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTOSIS; MYDRIASIS; NAUSEA AND VOMITING; RHABDOMYOLYSIS; SEROTONIN SYNDROME; SOMNOLENCE; SUSTAINED RELEASE FORMULATION; SWEATING; SYMPTOMATOLOGY; TACHYCARDIA; TONIC CLONIC SEIZURE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CREATINE KINASE; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; OVERDOSE; RHABDOMYOLYSIS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 26044470172     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rudolph RL, Derivan AT. The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. J Clin Psychopharmacol 1996;16:54S-61S.
2. Kent JM. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet 2000;355:911-18.
3. Gutierrez MA, Stimmel GL, Aiso JY. Venlafaxine: a 2003 update. Clin Ther. 2003; 25(8):2138-54.
4. Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol. 2004;42(1):67-71.
5. Blythe D, Hackett LP. Cardiovascular and neurological toxicity of venlafaxine. Hum Exp Toxicol. 1999;18(5):309-313.
6. White CM, Gailey RA, Levin GM, Smith T. Seizure resulting from a venlafaxine overdose. Ann Pharmacother. 1997;31(2):178-180.
7. Boyer EW, Shannon MPH. The Serotonin Syndrome. N Engl J Med. 2005;352:1112-20.
8. Pann JJ, Shen WW. Serotonin syndrome induced by venlafaxine. Ann Pharmacother. 2003;37(2):209-211.
9. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148:705-713.
10. Oliver JJ, Kelly C, Jarvie D, Denieul S, Bateman DN. Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reports. Human & Experimental Toxicology 2002;21:463-466.
11. Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002;325:1332.
12. Healy D. Lines of evidence on the risk of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom 2003;72:71.
13. www.fda.gov/antidepressants.